These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3276544

  • 1. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

  • 2. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).
    Deconinck E, Tamayo E, Hervé P.
    Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586
    [Abstract] [Full Text] [Related]

  • 3. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM, Gulati SC.
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [Abstract] [Full Text] [Related]

  • 4. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M, Naparstek E, Slavin S.
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A, Poloni A, Montanari M, Cantori I, Corvatta L, Masia MC, Curzi L, Mancini S, Leoni P.
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P, Pulsoni A, Sandrelli A, Simone F, Amadori S, Meloni G, Mandelli F.
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [Abstract] [Full Text] [Related]

  • 7. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S, Mumcuoglu M, Landesberg-Weisz A, Kedar E.
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Chang TT, Gulati SC, Chou TC, Vega R, Gandola L, Ibrahim SM, Yopp J, Colvin M, Clarkson BD.
    Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V.
    Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
    [Abstract] [Full Text] [Related]

  • 11. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L, Laporte JP, Mary JY, Lopez M, Lemonnier MP, Stachowiak J, Benitez O, Deloux J, Najman A, Salmon C.
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M, Mary JY, Sainteny F.
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
    Douay L, Mary JY, Giarratana MC, Najman A, Gorin NC.
    Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V, Kabral A, Bradstock KF.
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [Abstract] [Full Text] [Related]

  • 18. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557.
    Sainteny F, Lopez M, Mary JY, Frindel E.
    Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.